Drugs Made In America Acquisition (DMIIR) Payables (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Payables of $99359.0 for Q4 2025, down 60.27% year-over-year from $250100.0 in Q4 2024, and up 2063.74% quarter-over-quarter from $4592.0 in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Payables (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Payables for 2 consecutive years, with $99359.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 60.27% year-over-year to $99359.0; the TTM figure through Dec 2025 stood at $99359.0 (down 60.27% YoY), while the FY2025 annual figure was $99359.0, down 60.27% from the prior year.
- Payables advanced to $99359.0 in Q4 2025 per DMIIR's latest filing, from $4592.0 in the prior quarter.
- Across five years, Payables topped out at $250100.0 in Q4 2024 and bottomed at $4592.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 8.00 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | - |
| 4 | Armada Acquisition | 666.23 Mn | 666.18 Mn | - | 5.39 Mn |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | - |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 58,428.00 |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | 1.18 Mn |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 37,265.00 |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 462,253.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 462,253.00 |
| Dec 31, 2025 | 99,359.00 |
| Sep 30, 2025 | 4,592.00 |
| Dec 31, 2024 | 250,100.00 |